No Contamination. The Land Holder must not use toxic materials or chemicals or do or use anything which may result in any solid, liquid or gaseous material being introduced into the water contained in any Infrastructure forming part of the Scheme.
No Contamination. Tenant shall not discharge, leak or emit, or permit to be discharged, leaked or emitted, any material into the atmosphere, ground, sewer system or any body of water, if such material (as reasonably determined by the Landlord or any government authority) does or may, pollute or contaminate the same, or may adversely affect (a) the health, welfare or safety or persons, whether located on the Premises or elsewhere, or (b) the condition, use or enjoyment of the Building or any other real or personal property.
No Contamination. When exchanging confidential information with a potential licensee or any other third party, each Party shall ensure that its confidential information not be contaminated by technical information received from third party (such as any information relating to any competing technology).
No Contamination. Except as set forth in Section 5.9 of the Disclosure Schedule, after due inquiry and investigation, the real property owned, leased or operated by O&H has never contained or had located thereon, or been used by previous owners and/or operators or O&H, for storage of, or construction with, any Hazardous Substance.
No Contamination. Owner shall not connect any part of Owner’s Irrigation Improvements to any part of the City’s potable water system. Owner shall not place or introduce into the System any matter, substance, chemical, or compound without written authorization from the City.
No Contamination. There is no Contaminant on, under or emanating from any land the existence of which was caused or contributed to by the Company other than as permitted under any Relevant Environmental Authority. This paragraph does not apply in respect of periods prior to the date of occupation of the Real Property by the Company.
No Contamination. (A) Tenant shall not cause contamination of the Generator Pad, the Demised Premises or the Building by toxic or hazardous substances, toxic or hazardous wastes, or emissions as may be defined under any Environmental Statute as may from time to time be enacted (collectively, "Hazardous Materials"). Tenant shall at all times handle Hazardous Materials in a manner which will not cause risk of contamination of the Generator Pad, the Complex, the Demised Premises, the Building or elsewhere or which would violate any Environmental Statute now in effect or which may later come in effect during the Term of the Lease. For purposes of this section, the term "contamination" shall mean the uncontained presence of any Hazardous Materials at the Generator Pad, the Complex, the Demised Premises, the Building or elsewhere arising from the Generator Pad by the Tenant, its employees, agents, invitees, or guests.
No Contamination. At time of delivery, one aliquot of prepared cells will be transferred to a tissue culture flask and placed in incubator at Merck as QC for contamination SUPPLIER will provide documentation on cell viability, cell density and volume for each cell delivery. This documentation will be signed by the Merck scientist that placed the order with SUPPLIER. SUPPLIER to keep one copy of signed delivery sheet on file and forward one copy to Xxxxxx Xxxx at Merck. All documentation thereof furnished by SUPPLIER are and shall remain MERCK’s property. SUPPLIER may use them only for the SERVICES for which they are produced and shall not use them for any other purpose. Monthly Quality and Schedule Performance summaries will be prepared by SUPPLIER and submitted to Xxxxxx Xxxx at Merck. C. Performance in Assay Incentive This incentive will be assessed on a quarterly basis This incentive applies only to screening-scale deliveries (not small deliveries for assay development) This incentive will be awarded based on Merck’s successful completion of cell based screens during the quarter under consideration. Determination that there may have been problems that were cell-performance related will be based solely on Merck’s assessment. SUPPLIER will earn a percentage of the maximum possible incentive (increase of 0.1 to multiplier) based on the number of assays with performance issues, as shown below: # of Assays with Performance Issues During the Quarter Under Review % of Max Incentive Earned 0 100 1 75 2 50 3 25 4 0 Merck will provide timely feedback to SUPPLIER on performance in assay issues. SCHEDULE C SCOPE OF SERVICES
1. Receive Cell Lines Transferred From Merck All cell lines transferred from Merck to SUPPLIER must be validated as Mycoplasma free using an independent testing company (Bionique M-250 test) using an indirect DNA-fluorochrome test and a direct Mycoplasma test. MERCK will continue to supply SUPPLIER with validated FBS and tissue culture antibiotics/selection reagents.
2. Cell Banking • Cell lines to be used for primary HTS will be banked at 30-40 frozen vials at greater than or equal to 10e7 cells/ml (1ml/vial) • Cell lines which will only be used for follow-up screens will be banked at 10 to 20 frozen vials at greater than or equal to 10e7 cells/ml (1ml/vial). • Cells that do not need to be passaged will not require cell banking. All frozen cell banks will be validated using a DNA fluorochrome test and an indirect test using an independent testing laboratory (Bio...
No Contamination. At time of delivery, one aliquot of prepared cells will be transferred to a tissue culture flask and placed in incubator at Merck as QC for contamination SUPPLIER will provide documentation on cell viability, cell density and volume for each cell delivery. This documentation will be signed by the Merck scientist that placed the order with SUPPLIER. SUPPLIER to keep one copy of signed delivery sheet on file and forward one copy to Axxxxx Xxxx at Merck. All documentation thereof furnished by SUPPLIER are and shall remain MERCK’s property. SUPPLIER may use them only for the SERVICES for which they are produced and shall not use them for any other purpose. Monthly Quality and Schedule Performance summaries will be prepared by SUPPLIER and submitted to Axxxxx Xxxx at Merck.
No Contamination. To the present and actual knowledge of the Chief Executive Officer and Principal Accounting Officer of Real Goods Solar, Inc., Seller has never received any written notice, evidence or indication which would not have otherwise been made available to Xxxx Xxxxxxxxx, that Hazardous Materials are present at, on, under or adjacent to the Property.
